Portfolio News
Sofinnova Capital
Nucana plc announces pricing of initial public offering
Nucana plc announces pricing of initial public offering
Related News
Sofinnova Partners announces Myricx Bio agrees to be acquired by Novartis
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board